IRM three-lens brief
Evidence-based stock research on IRM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
IRM moved -0.21% overnight.
- Trading >3% below the 50-day MA — short-term weakness.
- P/E of 130 — priced for high growth; little margin of safety.
- Negative free cash flow last quarterly (-$499.46M).
IRM closed at $119.23 (-0.21%) as of 2026-07-10. Market cap: $35.47B. P/E (trailing) 129.6. Price is below the 50-day MA and above the 200-day MA. Concerns: trading >3% below the 50-day MA — short-term weakness.; p/E of 130 — priced for high growth; little margin of safety.. Last quarter: Revenue $1.94B, net income $143.66M, free cash flow -$499.46M.
Why three lenses on IRM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine IRMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/IRM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath IRM brief"></iframe>